Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2016 - 2025)

Avanos Medical (AVNS) has disclosed Non-Current Deferred Tax Liability for 12 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 10.91% to $6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, up 10.91% year-over-year, with the annual reading at $6.1 million for FY2025, 10.91% up from the prior year.
  • Non-Current Deferred Tax Liability hit $6.1 million in Q4 2025 for Avanos Medical, down from $6.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $71.1 million in Q4 2022 to a low of $5.5 million in Q4 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $22.7 million across 5 years, with a median of $22.6 million in 2023.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: skyrocketed 560.71% in 2022 and later plummeted 92.22% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $11.9 million in 2021, then skyrocketed by 497.48% to $71.1 million in 2022, then fell by 0.56% to $70.7 million in 2023, then tumbled by 92.22% to $5.5 million in 2024, then rose by 10.91% to $6.1 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for AVNS at $6.1 million in Q4 2025, $6.3 million in Q3 2025, and $6.3 million in Q2 2025.